Egyptian Pharmaceutical Journal

Scope & Guideline

Bridging academia and practice in pharmaceutical research.

Introduction

Explore the comprehensive scope of Egyptian Pharmaceutical Journal through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Egyptian Pharmaceutical Journal in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1687-4315
PublisherWOLTERS KLUWER MEDKNOW PUBLICATIONS
Support Open AccessNo
CountryIndia
TypeJournal
Convergefrom 2019 to 2024
AbbreviationEGYPT PHARM J / Egypt. Pharm. J.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressWOLTERS KLUWER INDIA PVT LTD, A-202, 2ND FLR, QUBE, C T S NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra 400059, INDIA

Aims and Scopes

The Egyptian Pharmaceutical Journal is dedicated to advancing the field of pharmaceutical sciences through innovative research and comprehensive reviews. The journal encompasses a wide range of topics related to pharmaceutical technology, drug development, and therapeutic applications, emphasizing both fundamental and applied aspects of the discipline.
  1. Pharmaceutical Research and Development:
    Focuses on the discovery, formulation, and testing of new drugs, including novel drug delivery systems and pharmacokinetics.
  2. Natural Product Research:
    Investigates the therapeutic potential of natural compounds, including their extraction, characterization, and biological activities.
  3. Pharmacology and Toxicology:
    Explores the effects of drugs and chemicals on biological systems, including studies on drug interactions, side effects, and the mechanisms of action.
  4. Clinical Pharmacy and Therapeutics:
    Examines the role of pharmacy in clinical settings, including medication management, patient adherence, and the evaluation of therapeutic outcomes.
  5. Biotechnology and Biopharmaceuticals:
    Researches the application of biotechnological methods in developing biological drugs, including monoclonal antibodies and gene therapies.
  6. Environmental and Industrial Pharmacy:
    Addresses the impact of pharmaceuticals on the environment and explores industrial processes in drug manufacturing and quality control.
The Egyptian Pharmaceutical Journal is witnessing an exciting evolution in its research themes, with several emerging scopes gaining traction. These trends reflect current advancements in pharmaceutical sciences and the growing interest in innovative therapeutic strategies.
  1. Nanotechnology in Drug Delivery:
    Research on the application of nanotechnology for drug delivery systems is rapidly increasing, focusing on enhancing bioavailability and targeting specific tissues or cells.
  2. Biopharmaceuticals and Biologics:
    There is a significant rise in studies related to biologics, including monoclonal antibodies and gene therapies, as the field moves towards more personalized medicine approaches.
  3. Pharmacogenomics and Personalized Medicine:
    Emerging research is focusing on the genetic factors influencing drug response, leading to more personalized therapeutic strategies based on individual genetic profiles.
  4. Immunotherapy and Cancer Research:
    The journal is seeing a surge in studies related to immunotherapy, particularly in cancer treatment, highlighting novel approaches to harnessing the immune system.
  5. Environmental Impact of Pharmaceuticals:
    Research addressing the environmental consequences of pharmaceutical waste and the fate of drugs in ecological systems is gaining importance, reflecting a broader awareness of sustainability in pharmacy.

Declining or Waning

While the Egyptian Pharmaceutical Journal continues to thrive in various domains of pharmaceutical research, certain themes have shown a decline in focus over recent years. These waning scopes reflect shifting priorities within the journal's publication trends.
  1. Traditional Herbal Medicine:
    Although herbal medicine remains relevant, there has been a noticeable decrease in the number of studies focusing solely on traditional herbal remedies compared to previous years.
  2. Basic Pharmacology Studies:
    Research that primarily focuses on basic pharmacological mechanisms without a direct clinical or therapeutic application is becoming less common in favor of studies with more immediate clinical relevance.
  3. In vitro Studies:
    While in vitro studies are foundational, there is a trend toward favoring in vivo studies and clinical trials that provide more applicable data for real-world therapeutic interventions.
  4. Pharmaceutical Chemistry Synthesis:
    Research focused on the chemical synthesis of pharmaceutical compounds is declining, as there is a growing emphasis on biological activities and applications of existing compounds rather than new synthetic pathways.
  5. Single-Agent Drug Studies:
    There is a reduction in the publication of studies examining the effects of single-agent drugs, as the trend shifts towards combination therapies and polypharmacy research.

Similar Journals

Journal of Pharmaceutical Policy and Practice

Bridging the gap between research and pharmaceutical practice.
Publisher: TAYLOR & FRANCIS LTDISSN: Frequency: 1 issue/year

Journal of Pharmaceutical Policy and Practice, published by Taylor & Francis Ltd, is a premier open access journal dedicated to advancing the field of pharmaceutical policy and practice. Launched in 2013, this esteemed journal has rapidly become a vital resource for researchers, practitioners, and policymakers alike, offering a critical examination of health policies and their implementation in pharmaceutical contexts. With an impressive impact factor reflecting its significance, it ranks in the Q2 category for Health Policy and Q1 in both Pharmacology, Toxicology and Pharmaceutics and Pharmacy, showcasing its high-quality contributions to the field. Accessible to a global audience since 2014, the journal disseminates innovative research findings that inform best practices, foster policy development, and enhance patient outcomes in the pharmaceutical landscape. Positioned in the UK and with strong Scopus rankings, specifically ranked #3 in Health Professions (Pharmacy), the journal serves as an essential platform for those striving to navigate the ever-evolving intersection of healthcare and pharmaceutical sciences.

Istanbul Journal of Pharmacy

Exploring new frontiers in drug formulation and delivery.
Publisher: ISTANBUL UNIV, FAC PHARMACYISSN: Frequency: 3 issues/year

Istanbul Journal of Pharmacy, published by Istanbul University, Faculty of Pharmacy, is a pivotal platform dedicated to the advancement of pharmaceutical sciences and technology. This journal serves as a vital resource for researchers, professionals, and students alike, seeking to disseminate cutting-edge research, reviews, and innovative methodologies within the pharmaceutical discipline. With a commitment to open access, the journal aims to foster a collaborative environment that promotes information sharing and scholarly discourse. The Istanbul Journal of Pharmacy invites submissions that delve into diverse topics ranging from drug formulation to pharmacokinetics, ensuring that readers are equipped with the latest insights and discoveries in the field. This journal is positioned to enhance scientific communication within the pharmaceutical community and support the continuous evolution of pharmacy practice and education globally.

Future Journal of Pharmaceutical Sciences

Fostering Knowledge Exchange in Pharmaceutical Sciences
Publisher: SPRINGERISSN: 2314-7245Frequency: 1 issue/year

The Future Journal of Pharmaceutical Sciences, published by Springer, stands as a vital resource in the realm of pharmaceutical research and innovation. Recognized for its open access initiative since 2015, this journal promotes extensive dissemination of cutting-edge discoveries, fostering collaboration among researchers, industry professionals, and students alike. With an ISSN of 2314-7245 and an E-ISSN of 2314-7253, it aims to bridge the gap between laboratory research and practical applications in the pharmaceutical sciences. Although specific metrics like HIndex and Scopus ranks are currently unavailable, the journal's commitment to high-quality, peer-reviewed content positions it as a promising platform for advancing pharmaceutical science. By engaging with this journal, contributors and readers can participate in the vibrant discourse shaping the future of drug development, therapeutic strategies, and healthcare solutions.

JOURNAL OF PHARMACY TECHNOLOGY

Innovating solutions for tomorrow's pharmaceutical challenges.
Publisher: SAGE PUBLICATIONS INCISSN: 8755-1225Frequency: 6 issues/year

JOURNAL OF PHARMACY TECHNOLOGY is a premier publication in the field of Pharmaceutical Science, established in 1989 and published by SAGE PUBLICATIONS INC. This journal serves as an essential resource for professionals, researchers, and students dedicated to the advancements in pharmacy technology and the application of innovative solutions in pharmaceutical practices. With an ISSN of 8755-1225 and an E-ISSN of 1549-4810, the journal provides a rigorous peer-reviewed platform for disseminating cutting-edge research and case studies. As of 2023, it is ranked Q3 in the Scopus categories of Pharmacology, Toxicology, and Pharmaceutics, highlighting its relevance in the field. Although it currently does not offer an Open Access option, JOURNAL OF PHARMACY TECHNOLOGY aims to remain a critical avenue for scholarly communication and knowledge dissemination among practitioners in the pharmaceutical sector, ensuring they stay informed of the latest trends and findings that impact their work.

Pharmacy Practice-Granada

Shaping the future of pharmacy through impactful scholarship.
Publisher: CENTRO INVESTIGACIONES & PUBLICACIONES FARMACEUTICASISSN: 1885-642XFrequency: 4 issues/year

Pharmacy Practice-Granada is an esteemed academic journal dedicated to advancing the field of pharmacy and pharmaceutical sciences. Published by CENTRO INVESTIGACIONES & PUBLICACIONES FARMACEUTICAS, this journal has been a pioneer in Open Access publishing since 2006, allowing researchers worldwide to disseminate their findings without barriers. Operating out of Spain, it provides a platform for innovative research and critical discourse in pharmaceutical practice and education. As of 2023, the journal is ranked in the Q2 category for Pharmaceutical Science and holds a prestigious Q1 ranking in Pharmacy, reflecting its impact and contribution within the academic community. With a strong Scopus ranking, positioned as #6 out of 45 in Health Professions – Pharmacy and a percentile of 87%, the journal serves as a vital resource for practitioners, researchers, and students alike who are committed to enhancing health outcomes through pharmacy. With a commitment to high-quality research, Pharmacy Practice-Granada aims to support knowledge exchange and foster collaborative efforts, ultimately shaping the future of pharmaceutical care.

TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH

Connecting scholars to tackle health challenges in the tropics.
Publisher: PHARMACOTHERAPY GROUPISSN: 1596-5996Frequency: 2 issues/year

Tropical Journal of Pharmaceutical Research is an esteemed open-access platform dedicated to advancing the field of pharmaceutical sciences, published by the Pharmacotherapy Group in Nigeria. With an ISSN of 1596-5996 and open access established since 2002, this journal serves as a critical resource for researchers, professionals, and students seeking to disseminate and access high-quality research in both pharmaceutical science and pharmacology. Despite its ranking in the third quartile (Q3) for Pharmaceutical Science and the fourth quartile (Q4) in Pharmacology as of 2023, the journal continues to stand out with its commitment to fostering significant dialogue and innovation in the scientific community. Anchored at the University of Benin, Faculty of Pharmacy, the journal invites contributions that explore novel pharmaceutical research, clinical applications, and drug development, playing a vital role in addressing health challenges that are particularly relevant to tropical regions. Researchers can look forward to publishing their findings in a journal that not only promotes the sharing of knowledge but also enhances the scientific discourse within a rapidly evolving field.

SAUDI PHARMACEUTICAL JOURNAL

Connecting researchers and professionals for impactful pharmaceutical advancements.
Publisher: ELSEVIERISSN: 1319-0164Frequency: 8 issues/year

SAUDI PHARMACEUTICAL JOURNAL, published by Elsevier, stands as a pivotal platform for scholarly communication within the realm of pharmaceutical sciences and pharmacology. With a commendable Q2 ranking in both Pharmaceutical Science and Pharmacology for 2023, this journal reflects a strong commitment to advancing scientific understanding and innovation. Open Access since 2009, the journal ensures that cutting-edge research is readily accessible to researchers, professionals, and students around the globe, fostering collaboration and knowledge sharing. Based in the Netherlands, the journal covers a wide scope of topics, contributing to a cumulative understanding of drug development, therapeutic strategies, and pharmaceutical education. With a significant presence in Scopus rankings—#57 in Pharmaceutical Science and #116 in Pharmacology—SAUDI PHARMACEUTICAL JOURNAL is a trusted resource for high-quality research that shapes the future of pharmaceutical sciences.

CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Unveiling Breakthroughs in Biotechnological Applications
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1389-2010Frequency: 15 issues/year

CURRENT PHARMACEUTICAL BIOTECHNOLOGY is a prestigious academic journal dedicated to advancing the field of pharmaceutical biotechnology by publishing high-quality research articles, reviews, and innovatory methodologies. Published by Bentham Science Publishers Ltd, this journal has established a strong reputation in its field, reflected in its 2023 Scopus rankings: it holds an impressive Q2 classification in Pharmaceutical Science and Q3 in Biotechnology, indicating its significant impact within these disciplines. With an ISSN of 1389-2010 and an E-ISSN of 1873-4316, CURRENT PHARMACEUTICAL BIOTECHNOLOGY provides a reliable platform for disseminating valuable research findings and fostering collaboration among researchers, professionals, and students alike. The journal covers a wide array of topics, from drug development and delivery systems to innovative biotechnological techniques, thus serving as an essential resource for anyone interested in the cross-section of pharmaceutical science and biotechnology. Researchers can access a diverse range of articles that explore both theoretical frameworks and practical applications, reflecting the ongoing evolution and challenges in this dynamic field.

Journal of Pharmacy and Bioallied Sciences

Bridging Theory and Practice in Bioengineering
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0976-4879Frequency: 6 issues/year

The Journal of Pharmacy and Bioallied Sciences is a premier open access publication that has been contributing to the fields of Pharmacy, Bioengineering, and Biochemistry since its establishment in India, under the esteemed Wolters Kluwer Medknow Publications. With the ISSN 0976-4879 and E-ISSN 0975-7406, this journal provides a platform for high-quality research articles, reviews, and clinical studies aimed at advancing knowledge and practice in the pharmaceutical and allied sciences. As a reflection of its academic stature, the journal holds a respectable categorization within the third and fourth quartiles in pertinent fields according to the latest metrics, with rankings that place it among prominent emerging research in pharmacology and biochemistry. Researchers and professionals are encouraged to access a wealth of knowledge freely, as the journal has been open access since 2010. The journal not only aims to foster innovative research but also strives to bridge the gap between pharmaceutical sciences and real-world applications, making it an essential resource for students, academics, and industry experts alike.

BIOLOGICAL & PHARMACEUTICAL BULLETIN

Advancing the Frontiers of Biomedicine and Drug Development
Publisher: PHARMACEUTICAL SOC JAPANISSN: 0918-6158Frequency: 12 issues/year

BIOLOGICAL & PHARMACEUTICAL BULLETIN, published by the PHARMACEUTICAL SOC JAPAN, is a prominent peer-reviewed journal that serves the fields of medicine, pharmaceutical science, and pharmacology. With an ISSN of 0918-6158 and an E-ISSN of 1347-5215, this publication has been crucial in disseminating innovative research since its inception in 1993, and it continues to contribute significantly to the body of knowledge as it converges towards 2024. Despite being classified as a non-open access journal, it maintains a respectable Q3 ranking in Medicine (miscellaneous) and Q2 in Pharmaceutical Science, highlighting its critical role in advancing scientific discourse in these areas. With Scopus rankings placing it in the 51st percentile for Pharmaceutical Science and 38th percentile for Pharmacology, BIOLOGICAL & PHARMACEUTICAL BULLETIN is an essential resource for researchers, professionals, and students looking to stay abreast of cutting-edge developments and trends in biomedicine and drug development.